Furthermore, we showed that CSF-1R inhibition significantly reduced the number of GAMMs infiltrating the glioma tissue, identified as CD68+ cells, and the inhibitory effect was detected also after brain repopulation. This evidence concerns the gene CSF1R and central nervous system cancer.